升级物流体系 开通化肥专列 在运营优化方面，该公司建立市场监测机制，通过大数据预判市场走势，灵活调整定价与库存策略。比 如农时旺季提前完成区域备货，淡季通过工业订单消化库存，有效实现供需动态平衡。 争取出口配额 拓展海外市场 面对国内化肥市场日趋激烈的竞争局面，丰喜集团主动谋变，将争取出口配额、拓展海外市场作为破解 产能消化难题、培育新增长极的核心战略。2025年，国家尿素出口配额总量设定在280万吨以内，出口 窗口期明确为5月至9月，配额采取分批次发放模式，市场竞争尤为激烈。 自7月初启动出口配额攻坚工作以来，丰喜集团依托多年积累的行业资源与渠道优势，携手大型农资合 作伙伴搭建高效出口贸易体系，全方位推进配额申报与海外市场对接；凭借长期严格履行国家化肥商业 储备任务、保障农资市场稳定供应的良好信誉与实力积淀，在多批次配额申报中持续发力。近日，国家 第四批尿素出口配额正式发放，丰喜集团凭借长期以来在国家化肥商业储备任务中的优异表现，成功获 批1万吨尿素配额。至此，该公司已累计获得6.1万吨2025年度尿素出口配额。 面对国内尿素产能过剩与结构性短缺并存的格局，丰喜集团从渠道、客户、产品运营3个方面发力，深 耕 ...

今年以来，国内尿素市场供强需弱格局凸显，尿素吨价始终在1600元左右周期性震荡。在此背景下，潞 安化工丰喜集团通过深耕国内市场、拓展海外布局、升级物流体系"三维"协同发力，1至10月尿素总销 量达104万吨，超额计划进度3.34个百分点，成功稳住经营基本盘。 深耕国内市场 激活需求潜力 面对国内尿素产能过剩与结构性短缺并存的格局，丰喜集团从渠道、客户、产品运营3个方面发力，深 耕终端市场，激活需求潜力。 在渠道布局方面，丰喜集团构建全覆盖、扁平化的营销网络，覆盖全国20多个省份；聚焦乡村合作社、 家庭农场、种粮大户，发展长期合作关系；依托铁路专线等物流优势，实现尿素直达田间地头，同时保 持高性价比报价；组建专业农化服务团队，为农户提供测土配方、用肥指导等服务；建立二维码追溯体 系，实现生产、质检、销售全流程可查，进一步夯实客户信任。 在客户对接方面，丰喜集团精准满足差异化需求，针对规模种植主体，推出"批量采购优惠+全程配 送"模式，适配集中采购需求；对中小农户，依托集团乡镇网格农资门店搭建便捷采购渠道，方便农户 就近购买，并与复合肥生产企业和山西农资供应商等工业客户签订长期合作协议。目前在丰喜集团，乡 村经营 ...

Core Viewpoint - Under the backdrop of the "dual carbon" goals driving deep adjustments in industrial structure, energy conservation and carbon reduction have become essential paths for high-quality development in chemical enterprises [1][2]. Group 1: Conceptual Innovation - The company aims to reshape the understanding of energy conservation and carbon reduction through a full-cycle value approach, recognizing that these efforts often involve equipment replacement, process adjustments, and even production line renovations, which require financial investment and may incur hidden costs [1]. - The company challenges the notion that energy conservation and carbon reduction equate to additional costs, instead viewing equipment updates and technological transformations as integral to the entire lifecycle, considering energy consumption and carbon emission costs across procurement, operation, maintenance, and elimination [1]. Group 2: Technological Empowerment - Technological innovation is identified as the core driving force for energy conservation and carbon reduction, with the company focusing on hardware optimization and precise replacements to reduce energy consumption from the source [2]. - The company emphasizes a tiered approach to phasing out high-energy-consuming equipment and replacing outdated electrical cabinets with energy-efficient models, ensuring that upgrades meet safety standards while continuously lowering energy consumption [2]. Group 3: Collaborative Approach - The company adopts an industry chain collaborative mindset to extend energy conservation and carbon reduction efforts beyond its own operations, creating a circular energy-saving system by transforming waste into raw materials and energy consumption into energy efficiency [2]. - The company actively participates in formulating industry standards, such as the "Green Factory Evaluation Requirements for Compound Fertilizer Industry" and the "Green Factory Evaluation Requirements for Monoammonium Phosphate and Diammonium Phosphate Industry," translating its carbon reduction practices into industry consensus [2]. Group 4: Strategic Integration - The path to energy conservation and carbon reduction for chemical enterprises is characterized by technological innovation, conceptual upgrades, and systemic restructuring, indicating that deep integration of energy conservation and carbon reduction with corporate strategy is essential for achieving low-carbon transformation and high-quality development [2].

为突破高气价困境提供创新解决方案 中化新网讯 "目前公司气改煤项目施工已经进入收尾阶段，今冬将可以用煤制合成气部分替代天然气作 为尿素原料，以缓解尿素成本倒挂压力。"11月13日，河南省中原大化集团有限责任公司党委工作部部 长郭红剑介绍说。 据了解，在天然气头化肥企业中，实施以公司煤化工甲醇装置煤制合成气部分替代天然气作为尿素原料 进行原料结构优化改造的，中原大化可谓首家，此举为气头尿素企业突破高气价困境提供了创新解决方 案。 中原大化前身是河南省中原化肥厂，以天然气为原料，年产30万吨合成氨、52万吨尿素。1990年建成投 产后，结束了河南省没有大化肥的历史，并首次采用高压氨气提工艺生产尿素，将我国化肥生产引向节 能环保方向。 作为中原油田的配套项目，中原大化在建设之初就拥有得天独厚的优势——使用来自中原油田的管道直 供天然气。这种供应模式距离短、成本相对较低，是保障其基础生产和生存的"生命线"。但随着中原油 田开采年限增加，天然气产量逐步衰减，完全依赖该油田供气已无法满足中原大化全部用气需求，特别 是扩产和新增项目的用气需求。 "在此背景下，中原大化实施了气头化肥原料路线优化改造项目，将煤化工煤气化原料气 ...

为突破高气价困境提供创新解决方案 中化新网讯 "目前公司气改煤项目施工已经进入收尾阶段，今冬将可以用煤制合成气部分替代天然气作 为尿素原料，以缓解尿素成本倒挂压力。"11月13日，河南省中原大化集团有限责任公司党委工作部部 长郭红剑介绍说。 据了解，在天然气头化肥企业中，实施以公司煤化工甲醇装置煤制合成气部分替代天然气作为尿素原料 进行原料结构优化改造的，中原大化可谓首家，此举为气头尿素企业突破高气价困境提供了创新解决方 案。 中原大化前身是河南省中原化肥厂，以天然气为原料，年产30万吨合成氨、52万吨尿素。1990年建成投 产后，结束了河南省没有大化肥的历史，并首次采用高压氨气提工艺生产尿素，将我国化肥生产引向节 能环保方向。 原料气尽管来源广泛，但均是从市场上采购来的高价天然气，这无形中抬高了中原大化的生产成本。近 年来，公司综合气价超过3元/立方米已是常事，企业不得不承受高成本重压。而尿素市场的持续低迷， 更令中原大化生产经营雪上加霜。 破局要靠主动创新 作为中原油田的配套项目，中原大化在建设之初就拥有得天独厚的优势——使用来自中原油田的管道直 供天然气。这种供应模式距离短、成本相对较低，是保障其基础生 ...

Group 1 - The report indicates that the A-share market is currently stabilizing around the 4000-point mark, which is expected to build a solid foundation for future gains and potentially reach new highs within the year [1][4][8] - The Shanghai Composite Index successfully broke through the 4025-point level, marking a new high for both the year and the past decade, with significant gains observed in sectors such as energy metals, batteries, and power equipment [1][5][8] - The report highlights that the market is optimistic about upcoming economic policy meetings in December, which are anticipated to provide positive signals for growth, consumption, and technological innovation [1][9] Group 2 - The report notes that while the market is expected to continue its upward trend, there may be volatility and divergence between index highs and individual stock adjustments due to profit-taking and cautious sentiment from outside investors [2][9][10] - It emphasizes the importance of timing in sector rotation strategies, recommending a balanced allocation and opportunistic buying in sectors with strong performance indicators, including technology growth areas and cyclical industries [2][10] - The report identifies that the energy metals and new energy sectors are experiencing significant growth, driven by supportive policies and a shift in the business model of the storage industry towards self-sustainability [6][7]

行业政策偏利好 转自：期货日报 近期，受第四批出口配额发布影响，尿素价格大幅反弹，主力合约最高涨至1679元／吨。后期随着利多 情绪逐步消化，价格再度回落。综合来看，一方面，供应持续高位运行，全国尿素日产量维持在19万吨 以上，库存压力凸显；另一方面，农业用肥进入淡季，工业需求恢复缓慢，且复合肥和秋季肥生产已结 束，市场逐步转为供大于求格局。目前尿素呈现明显的震荡特征，期价或在1600~1700元／吨区间内反 复波动。不过，后期气头企业检修可能带来供应减量，淡储需求也将逐步启动，加之原料端表现强势， 上述因素将对行情形成一定支撑。 储备性需求增加 2025年尿素产能仍处于集中投放阶段，截至11月已投产尿素产能达630万吨。当前尿素日产量长期维持 在19万吨以上，最高接近21万吨。最新数据显示，当前尿素日产量为19.8万吨。在高日产量背景下，行 业库存持续处于历史高位。据卓创资讯统计，2025年尿素企业库存多数时间维持在100万吨以上，最高 达到170万吨，处于历年高位水平。 不过，11月中旬之后，国内气头尿素装置将步入检修季。加之当前行业处于亏损状态，装置检修概率或 高于往年。据统计，全国气头尿素日产量约4. ...

"这辈子还能解套吗？ "一位股民在股票论坛发出绝望的提问。 他口中的这只股票，上市6天连续下跌，首日追高者浮亏已超45%。 更残酷的是，根据Wind数据统计，今年A股上市的48只新股中，若投资者在上市首日以收盘价买入并长期持有，七成以上将面临亏损，最高亏损幅度达 47%。 股价腰斩后仍高估一倍 即便经历暴跌，许多新股的估值仍远高于行业合理水平。 前述汽车零部件企业市盈率61倍，高出行业均值一倍多。 红四方在腰斩后市盈率仍达86倍，而行 业平均仅15倍。 有基金经理测算，若按20倍市盈率估算，其合理股价应在21元左右，但当前股价仍达81元。 这场看似疯狂的"上市即巅峰"戏码，已成为A股新股的常态。 一场精心设计的"围猎游戏" 2024年11月26日，化肥企业红四方登陆A股。 发行价仅7.98元的它，首日涨幅一度飙升至2255%，盘中最高触及188元。 但狂欢仅持续了一天。 次日，股价腰斩49.7%，收于81元。 类似的剧情在2024年反复上演：长联科技上市次日冲高至689元后暴跌86%；强邦新材从245元跌至48元，跌幅81%；盟固利首日暴涨35倍后，从202元阴跌 至15元，跌幅93%。 这些新股背后存在共性 ...

Core Viewpoint - Shandong Agricultural University Fertilizer Technology Co., Ltd. (referred to as "the company") is facing challenges in its IPO process, with declining revenue, shrinking orders, and pressure on core product prices, despite its leading position in the niche fertilizer market [1][3][4]. Financial Performance - The company's revenue has shown a downward trend from 26.76 billion yuan in 2022 to an estimated 14.95 billion yuan in the first half of 2025 [3][4]. - Net profit figures have remained relatively stable, with 1.01 billion yuan in 2022 and 1.26 billion yuan in the first half of 2025, indicating a situation of "profit increase without revenue increase" [4]. - Revenue from the new fertilizer business decreased from 19.68 billion yuan in 2022 to 19.24 billion yuan in 2024, with average prices dropping from 2842 yuan/ton to 2596 yuan/ton [4]. Order Backlog - The company's order backlog has been declining, with amounts of 6.29 billion yuan in 2022, 4.7 billion yuan in 2023, and further down to 1.40 billion yuan by June 30, 2025 [8]. - The decrease in orders is attributed to falling raw material prices, leading to more conservative purchasing behavior from customers [8]. IPO Fundraising and Project Adjustments - The company plans to raise 4.13 billion yuan through its IPO, down from an initial target of 5.52 billion yuan, with significant cuts to its fundraising projects [9][12]. - The company has canceled the "15,000 tons of micro-ecological preparation series production project" and reduced the amount allocated for working capital by 10 million yuan [12]. Industry Context - The overall industry is not performing well, with the average capacity utilization rate for compound fertilizers in China expected to be only 28.61% in 2024, while new capacity is still being added [13]. - The company has maintained a high dividend payout ratio, distributing 1.8 billion yuan in dividends over the past three years, which raises questions about its cash flow management amid declining revenues [13]. Inventory and Related Transactions - The company's inventory value has been significant, accounting for 30% of current assets, with a notable risk of price declines in the fertilizer market [14]. - The company has faced scrutiny regarding the fairness of pricing in related transactions, particularly with its actual controller's company, which has raised concerns about potential profit transfers [18][19].

Financial Data and Key Metrics Changes - Total revenues for Q1 2026 were $77.5 million, a 17% decline compared to the same period last year, primarily due to the transition towards a more scalable seed business model and lower-margin sales [8][9] - Gross profit remained almost equal at $36 million, with a gross margin expansion of 650 basis points, reflecting improved product mix and margin expansion [4][11] - Adjusted EBITDA for the quarter was $13.6 million, a 61% increase compared to $8.5 million in the same period last year, driven by a significant reduction in operating costs [12] Business Line Data and Key Metrics Changes - Crop protection revenues were $39.9 million, a 16% decline year-over-year, attributed to sluggish demand in Argentina and lower sales in the US and Brazil [8][9] - Seed and integrated products revenues were $12.6 million, a 37% decline compared to last year, expected to continue for at least two more quarters due to the unwinding of the HB4 downstream program [9][10] - Crop nutrition revenues were $25.1 million, broadly in line with last year, with higher biostimulant sales offset by weaker fertilizer dynamics [10] Market Data and Key Metrics Changes - Demand for microbe-based fertilizers improved in Argentina, particularly in terms of volume, supported by strong corn planting intentions, although delayed purchases in Paraguay and Uruguay offset these gains [10] - The company noted sluggish demand in Argentina for crop protection products, with tight credit conditions and uncertainty ahead of midterm elections impacting sales [9] Company Strategy and Development Direction - The company is focused on improving the quality of revenues, protecting margins, and operating with discipline while pursuing its core purpose of enabling better agriculture [5][6] - A target was set to operate above a 40% gross margin level, achieve profitability above 20% of adjusted EBITDA over sales, and reduce annual SG&A costs by $10-$12 million [6][12] Management Comments on Operating Environment and Future Outlook - Management acknowledged the complex operating environment but emphasized a disciplined approach to profitability, liquidity, and capital efficiency [16] - The company is actively managing liquidity and debt maturities while maintaining constructive dialogue with lenders [16] Other Important Information - Total financial debt as of September 30, 2026, was $242.5 million, down from $260.2 million, primarily due to the repayment of working capital loans in Argentina [14] - Cash, cash equivalents, and short-term investments totaled $16.6 million, resulting in a net financial debt of $225.9 million, essentially flat versus the prior quarter [16] Q&A Session Summary Question: Potential for imports from Argentina to the US post-election - Management noted that beef production and profitability in Argentina are high, and the low tariff classification could benefit the company in serving the US market with Argentine-manufactured ag input products [18] Question: Status of Corteva sales of biopesticides into Europe - Management indicated that there are currently no bioprotection products registered in Europe, but biostimulant sales have improved in Argentina and Latin America, with Corteva Europe sales expected later in the year [19]